128 related articles for article (PubMed ID: 21349756)
1. Evaluation of the moisturizer Pédimed(®) in the foot care of diabetic patients.
Garrigue E; Martini J; Cousty-Pech F; Rouquier A; Degouy A
Diabetes Metab; 2011 Sep; 37(4):330-5. PubMed ID: 21349756
[TBL] [Abstract][Full Text] [Related]
2. A prospective, randomized, controlled double-blind study of a moisturizer for xerosis of the feet in patients with diabetes.
Pham HT; Exelbert L; Segal-Owens AC; Veves A
Ostomy Wound Manage; 2002 May; 48(5):30-6. PubMed ID: 12046488
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of an emollient cream in the treatment of xerosis in diabetic foot: a double-blind, randomized, vehicle-controlled clinical trial.
Martini J; Huertas C; Turlier V; Saint-Martory C; Delarue A
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):743-747. PubMed ID: 27997725
[TBL] [Abstract][Full Text] [Related]
4. Use of a urea, arginine and carnosine cream versus a standard emollient glycerol cream for treatment of severe xerosis of the feet in patients with type 2 diabetes: a randomized, 8 month, assessor-blinded, controlled trial.
Federici A; Federici G; Milani M
Curr Med Res Opin; 2015 Jun; 31(6):1063-9. PubMed ID: 25851453
[TBL] [Abstract][Full Text] [Related]
5. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
Karabulut AA; Izol Serel B; Eksioglu HM
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
[TBL] [Abstract][Full Text] [Related]
6. An urea, arginine and carnosine based cream (Ureadin Rx Db ISDIN) shows greater efficacy in the treatment of severe xerosis of the feet in Type 2 diabetic patients in comparison with glycerol-based emollient cream. A randomized, assessor-blinded, controlled trial.
Federici A; Federici G; Milani M
BMC Dermatol; 2012 Sep; 12():16. PubMed ID: 23009311
[TBL] [Abstract][Full Text] [Related]
7. Fungal chitin-glucan scaffold for managing diabetic xerosis of the feet in menopausal women.
Quatresooz P; Piérard-Franchimont C; Szepetiuk G; Devillers C; Piérard GE
Expert Opin Pharmacother; 2009 Oct; 10(14):2221-9. PubMed ID: 19743936
[TBL] [Abstract][Full Text] [Related]
8. Treatment by a moisturizer of xerosis and cracks of the feet in men and women with diabetes: a randomized, double-blind, placebo-controlled study.
Gin H; Rorive M; Gautier S; Condomines M; Saint Aroman M; Garrigue E
Diabet Med; 2017 Sep; 34(9):1309-1317. PubMed ID: 28627029
[TBL] [Abstract][Full Text] [Related]
9. The influence of a humectant-rich mixture on normalz skin barrier function and on once- and twice-daily treatment of foot xerosis. A prospective, randomized, evaluator-blind, bilateral and untreated-control study.
Lodén M; von Scheele J; Michelson S
Skin Res Technol; 2013 Nov; 19(4):438-45. PubMed ID: 23521561
[TBL] [Abstract][Full Text] [Related]
10. The effect of polyneuropathy on foot microcirculation in Type II diabetes.
Nabuurs-Franssen MH; Houben AJ; Tooke JE; Schaper NC
Diabetologia; 2002 Aug; 45(8):1164-71. PubMed ID: 12189447
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous anaesthesia of the lower leg can improve sensibility in the diabetic foot. A double-blind, randomized clinical trial.
Lundborg GN; Björkman AC; Rosén BN; Nilsson JA; Dahlin LB
Diabet Med; 2010 Jul; 27(7):823-9. PubMed ID: 20636964
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
13. The 24-hr, 28-day, and 7-day post-moisturizing efficacy of ceramides 1, 3, 6-II containing moisturizing cream compared with hydrophilic cream on skin dryness and barrier disruption in senile xerosis treatment.
Lueangarun S; Tragulplaingam P; Sugkraroek S; Tempark T
Dermatol Ther; 2019 Nov; 32(6):e13090. PubMed ID: 31585489
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial.
Nuttall T; Mueller R; Bensignor E; Verde M; Noli C; Schmidt V; Rème C
Vet Dermatol; 2009 Jun; 20(3):191-8. PubMed ID: 19374721
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
Tosti A; Iorizzo M; Botta GL; Milani M
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
[TBL] [Abstract][Full Text] [Related]
16. Specific gel-cream as adjuvant to oral isotretinoin improved hydration and prevented TEWL increase--a double-blind, randomized, placebo-controlled study.
Herane MI; Fuenzalida H; Zegpi E; De Pablo C; Espadas MJ; Trullás C; Mirada A; Martin GG
J Cosmet Dermatol; 2009 Sep; 8(3):181-5. PubMed ID: 19735515
[TBL] [Abstract][Full Text] [Related]
17. Xerosis of the feet: a comparative study on the effectiveness of two moisturizers.
Baalham P; Birch I; Young M; Beale C
Br J Community Nurs; 2011 Dec; 16(12):591-2, 594-7. PubMed ID: 22413404
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of topical 10% urea-based lotion in patients with ichthyosis vulgaris: a two-center, randomized, controlled, single-blind, right-vs.-left study in comparison with standard glycerol-based emollient cream.
Tadini G; Giustini S; Milani M
Curr Med Res Opin; 2011 Dec; 27(12):2279-84. PubMed ID: 22007909
[TBL] [Abstract][Full Text] [Related]
19. Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers.
Martínez-de Jesús FR; Morales-Guzmán M; Castañeda M; Pérez-Morales A; García-Alonso J; Mendiola-Segura I
Arch Med Res; 1997; 28(1):95-9. PubMed ID: 9078595
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled clinical study to evaluate the effectiveness of an active moisturizing lotion with colloidal oatmeal skin protectant versus its vehicle for the relief of xerosis.
Kalaaji AN; Wallo W
J Drugs Dermatol; 2014 Oct; 13(10):1265-8. PubMed ID: 25607563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
